Sai Life Sciences IPO is being structured as a book-built issue of ₹3,042.62 crores. It is comprised of a fresh issue of 1.73 crore shares, aggregating ₹950.00 crores, and an offer for sale of 3.81 crore shares, aggregating ₹2,092.62 crores.
The IPO is scheduled to be opened for subscription on December 11, 2024, and closed on December 13, 2024. The allotment is expected to be finalized on Monday, December 16, 2024. The IPO is planned to be listed on BSE and NSE, with the tentative listing date set as Wednesday, December 18, 2024.
The price band for Sai Life Sciences IPO has been set between ₹522 and ₹549 per share. A minimum lot size of 27 shares is required for an application. The minimum investment amount for retail investors is set at ₹14,823. For sNII, the minimum lot size of 14 lots (378 shares) amounts to ₹207,522, and for bNII, 68 lots (1,836 shares) amounts to ₹1,007,964.
Sai Life Sciences Limited Timeline (Tentative Schedule)
Sai Life Sciences Limited IPO opens on December 11, 2024, and closes on December 13, 2024.
IPO Open Date
December 11, 2024
IPO Close Date
December 13, 2024
Basis of Allotment
December 16, 2024
Initiation of Refunds
December 17, 2024
Credit of Shares to Demat
December 17, 2024
Listing Date
--
Cut-off time for UPI mandate confirmation
December 13, 2024
Sai Life Sciences Limited IPO Lot Size
A minimum of 27 shares and multiples thereof can be bid by investors. The minimum and maximum investments by retail investors and HNIs, in terms of shares and amount, are depicted in the table below.
Application
Lots
Shares
Amount
Retail (Min)
1
27
Rs.14,823
Retail (Max)
13
351
Rs.192,699
S-HNI (Min)
14
378
Rs.207,522
S-HNI (Max)
67
1,809
Rs.993,141
B-HNI (Min)
68
1,836
Rs.1,007,964
HNI (Min)
Sai Life Sciences Limited IPO Promoter Holding
Share Holding Pre Issue
40.48%
Share Holding Post Issue
Sai Life Sciences Limited IPO Reservation
Investor Category
Shares Offered
Maximum Allottees
Anchor Investor Shares Offered
Market Maker Shares Offered
Other Shares Offered
QIB Shares Offered
Not more than 50% of the Net Issue
NII (HNI) Shares Offered
Not less than 15% of the Net Issue
bNII > ₹10L
sNII < ₹10L
Retail Shares Offered
Not less than 35% of the Net Issue
Employee Shares Offered
Total Shares Offered
Sai Life Sciences Limited IPO Anchor Investors Details
Bid Date
Shares Offered
Anchor Portion Size (In Cr.)
Anchor lock-in period end date for 50% shares (30 Days)
Anchor lock-in period end date for remaining shares (90 Days)
About Sai Life Sciences Limited
Incorporated in January 1999, Sai Life Sciences Limited is engaged in the research, development, and manufacturing of small-molecule new chemical entities. Tailor-made services are offered to biotech firms and global pharma companies.
In the Financial Year 2024 and the month ending September 30, 2024, services were provided to over 280 innovator pharmaceutical companies, including more than 230 during that month. Among these clients, 18 of the top 25 pharmaceutical companies by revenue in the calendar year 2023 were served. These services were offered across regions including the US, the UK, Europe, and Japan.
The company’s business development team is comprised of 16 experienced and qualified professionals, with six based in the US, nine in the UK and Europe, and one in Japan.
The following service offerings are provided by the company:
Capabilities in chemistry, manufacturing, and control (“CMC”) and contract development and manufacturing organisations (“CDMO”).
CRO services, including integrated discovery (“Discovery”) capabilities across biology, chemistry, and drug metabolism and pharmacokinetics.
As of September 30, 2024, a total of 2,353 scientific staff were employed by the company, with the majority holding advanced degrees, including 302 Ph.D.s and 1,475 master’s degrees.
Additionally, as of September 30, 2024, the company’s workforce consisted of 3,135 employees with expertise across the CRDMO value chain.
Key Performance Indicator
KPI
Values
ROE
11.79%
ROCE
15.96%
Debt/Equity
RoNW
8.13%
P/BV
10.18
PAT Margin (%)
5.65
Pre IPO
Post IPO
EPS (Rs)
4.34
2.69
P/E (x)
126.42
203.82
Objects of the Issue (Sai Life Sciences Limited IPO Objectives)
The Net Proceeds are proposed to be utilized for funding the following purposes:
The repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the Company.
The Sai Life Sciences Limited IPO is classified as an Mainline IPO. The issue price is set between ₹522 and ₹549 per equity share. A minimum of 27 shares is required per order. The IPO will be open from December 11, 2024, to December 13, 2024. The shares are proposed to be listed on BSE, NSE.
When does the Sai Life Sciences Limited IPO open and close?
The Sai Life Sciences Limited IPO will be opened on December 11, 2024, and closed on December 13, 2024.
What is the issue size of the Sai Life Sciences Limited IPO?
The size of the Sai Life Sciences Limited IPO is in total. A fresh issue of ₹950.00 Cr shares, aggregating up to , is included.
What is the price band of the Sai Life Sciences Limited Limited IPO?
The price band for the IPO has been set between ₹522 - ₹549 per equity share.
What is the allotment date of the Sai Life Sciences Limited IPO?
The share allotment date for the Sai Life Sciences Limited IPO is set for December 16, 2024.
What is the Sai Life Sciences Limited listing date?
The Sai Life Sciences Limited IPO is scheduled to be listed on November 30, -0001.